Journal article · 2016 · Open access

Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials

Meaghan Krohe, Yanni Hao, Roger E. Lamoureux, Nina Galipeau, DENISE R. GLOBE, Catherine Foley, Iyar Mazar, Jeffrey Solomon, Alan L. Shields

Breast Cancer Basic and Clinical Research, 10, BCBCR.S39385 · Published 1 January 2016 · DOI 10.4137/bcbcr.s39385

Open full textCite this paper

In brief

“Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials” is a 2016 journal article by Meaghan Krohe and 8 co-authors, published in Breast Cancer Basic and Clinical Research. OpenAlex counts 28 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Breast Cancer Basic and Clinical Research.

Citations
28
Most cited in
2017 (4)
Field-weighted impact
1.27
References
9
Authors
9

Abstract

INTRODUCTION: Patient-reported outcome (PRO) measures serve to capture vital patient information not otherwise obtained by primary study endpoints. This paper examines how PROs are utilized as endpoints in industry-sponsored metastatic breast cancer clinical trials. METHODS: A search was conducted in the clinicaltrials.gov web site for trials involving common treatments for metastatic breast cancer. Thirty-eight clinical trials were identified which included a PRO endpoint in the study, and data were extracted and summarized. RESULTS: Overall, 17 unique PRO questionnaires and 14 concepts of measurement were identified as secondary or exploratory endpoints. The Functional Assessment of Cancer Therapy-Breast was the most frequently utilized questionnaire, commonly implemented to assess quality of life. The EORTC QLQ-C30 was also frequently used to measure quality of life or pain. CONCLUSION: This review shares insights into the role of PROs in trials for metastatic breast cancer from which treatment developers and other stakeholders can enhance successful implementation of the patient voice into future trials.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Krohe, M., Hao, Y., Lamoureux, R. E., Galipeau, N., GLOBE, D. R., Foley, C., Mazar, I., Solomon, J., & Shields, A. L. (2016). Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials. Breast Cancer Basic and Clinical Research, 10, BCBCR.S39385. https://doi.org/10.4137/bcbcr.s39385

MLA 9

Krohe, Meaghan, et al. “Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials.” Breast Cancer Basic and Clinical Research, vol. 10, 2016, p. BCBCR.S39385. https://doi.org/10.4137/bcbcr.s39385.

Chicago

Krohe, Meaghan, Yanni Hao, Roger E. Lamoureux, Nina Galipeau, DENISE R. GLOBE, Catherine Foley, Iyar Mazar, Jeffrey Solomon, and Alan L. Shields. 2016. “Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials.” Breast Cancer Basic and Clinical Research 10: BCBCR.S39385. https://doi.org/10.4137/bcbcr.s39385.

Harvard

Krohe, M. et al. (2016) ‘Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials’, Breast Cancer Basic and Clinical Research, 10, p. BCBCR.S39385. doi:10.4137/bcbcr.s39385.

IEEE

M. Krohe et al., “Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials,” Breast Cancer Basic and Clinical Research, vol. 10, p. BCBCR.S39385, 2016, doi: 10.4137/bcbcr.s39385.

BibTeX

@article{krohe2016patient,
  title     = {{Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials}},
  author    = {Krohe, Meaghan and Hao, Yanni and Lamoureux, Roger E. and Galipeau, Nina and GLOBE, DENISE R. and Foley, Catherine and Mazar, Iyar and Solomon, Jeffrey and Shields, Alan L.},
  journal   = {Breast Cancer Basic and Clinical Research},
  year      = {2016},
  volume    = {10},
  pages     = {BCBCR.S39385},
  doi       = {10.4137/bcbcr.s39385},
  url       = {https://doi.org/10.4137/bcbcr.s39385}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201744
201822
201933
202044
202122
202244
202333
202433
202522
202611

Its field-weighted citation impact is 1.27: it has been cited 1.27 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • patient-reported outcomes
  • metastatic breast cancer
  • industry-sponsored trials
  • quality of life
  • functional assessment
  • EORTC QLQ-C30
  • pain assessment
  • patient voice

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Krohe, M., Hao, Y., Lamoureux, R. E., Galipeau, N., GLOBE, D. R., Foley, C., Mazar, I., Solomon, J., & Shields, A. L. (2016). Patient-Reported Outcomes in Metastatic Breast Cancer: A Review of Industry-Sponsored Clinical Trials. Breast Cancer Basic and Clinical Research, 10, BCBCR.S39385. https://doi.org/10.4137/bcbcr.s39385

How many times has this paper been cited?

28 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Breast Cancer Basic and Clinical Research: sign in and open the full text from this page.

Who wrote this paper?

Meaghan Krohe, Yanni Hao, Roger E. Lamoureux, Nina Galipeau, DENISE R. GLOBE, Catherine Foley, Iyar Mazar, Jeffrey Solomon, Alan L. Shields.

What is the DOI of this paper?

10.4137/bcbcr.s39385, permanently at https://doi.org/10.4137/bcbcr.s39385. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.